158 related articles for article (PubMed ID: 37490413)
1. Immunohistochemistry in the Diagnosis and Classification of Breast Tumors.
Sun H; Ding Q; Sahin AA
Arch Pathol Lab Med; 2023 Oct; 147(10):1119-1132. PubMed ID: 37490413
[TBL] [Abstract][Full Text] [Related]
2. Update on Immunohistochemical Analysis in Breast Lesions.
Peng Y; Butt YM; Chen B; Zhang X; Tang P
Arch Pathol Lab Med; 2017 Aug; 141(8):1033-1051. PubMed ID: 28574279
[TBL] [Abstract][Full Text] [Related]
3. Use of Immunohistochemical Stains in Epithelial Lesions of the Breast.
Khazai L; Rosa M
Cancer Control; 2015 Apr; 22(2):220-5. PubMed ID: 26068768
[TBL] [Abstract][Full Text] [Related]
4. Use of immunohistochemistry in the diagnosis of problematic breast lesions.
Lee AH
J Clin Pathol; 2013 Jun; 66(6):471-7. PubMed ID: 23486609
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors.
McCluggage WG; Young RH
Semin Diagn Pathol; 2005 Feb; 22(1):3-32. PubMed ID: 16512597
[TBL] [Abstract][Full Text] [Related]
6. Differences in immunohistochemistry utilization by general and breast subspecialty pathologists at a large academic institution.
Compton ML; Hogan M; Reisenbichler ES
Ann Diagn Pathol; 2019 Oct; 42():92-95. PubMed ID: 31445409
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of immunohistochemistry for differential diagnosis between benign and malignant breast lesions.
Moriya T; Kanomata N; Kozuka Y; Fukumoto M; Iwachido N; Hata S; Takahashi Y; Miura H; Ishida K; Watanabe M
Breast Cancer; 2009; 16(3):173-8. PubMed ID: 19475479
[TBL] [Abstract][Full Text] [Related]
8. DOG-1 as a Myoepithelial Marker in Discriminating Invasive Breast Carcinomas From Non-Invasive Breast Lesions.
Perumandal S; Ponnaboina DM; Moula MC; Rajan YR
Cureus; 2023 May; 15(5):e39676. PubMed ID: 37398743
[TBL] [Abstract][Full Text] [Related]
9. Interpathologist Diagnostic Agreement for Non-Small Cell Lung Carcinomas Using Current and Recent Classifications.
Funkhouser WK; Hayes DN; Moore DT; Funkhouser WK; Fine JP; Jo H; Nikolaishvilli-Feinberg N; Eeva M; Grilley-Olson JE; Banks PM; Graziano P; Boswell EL; Elmberger G; Raparia K; Hart CF; Sholl LM; Nolan NJ; Fritchie KJ; Pouagare E; Allen TC; Volmar KE; Biddinger PW; Kleven DT; Papez MJ; Spencer DV; Rekhtman N; Mino-Kenudson M; Hariri L; Driver B; Cagle PT
Arch Pathol Lab Med; 2018 Dec; 142(12):1537-1548. PubMed ID: 29708428
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Pitfalls in Breast Cancer Pathology With an Emphasis on Core Needle Biopsy Specimens.
Quintana LM; Collins LC
Arch Pathol Lab Med; 2023 Sep; 147(9):1025-1038. PubMed ID: 37651393
[TBL] [Abstract][Full Text] [Related]
11. Salivary Gland-Type Carcinomas of the Breast: A Review and Update With Emphasis on Molecular Advances and Differential Diagnosis.
Pesoli C; Youssef M; Wei S
Arch Pathol Lab Med; 2022 Nov; 146(11):1319-1328. PubMed ID: 35862856
[TBL] [Abstract][Full Text] [Related]
12. GATA binding protein 3 (GATA3) as a marker for metaplastic spindle cell carcinoma of the breast.
Jin C; Hacking S; Sajjan S; Kamanda S; Bhuiya T; Nasim M
Pathol Res Pract; 2021 May; 221():153413. PubMed ID: 33770555
[TBL] [Abstract][Full Text] [Related]
13. An immunohistochemical panel to differentiate metastatic breast carcinoma to skin from primary sweat gland carcinomas with a review of the literature.
Rollins-Raval M; Chivukula M; Tseng GC; Jukic D; Dabbs DJ
Arch Pathol Lab Med; 2011 Aug; 135(8):975-83. PubMed ID: 21809988
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Machine Learning of Breast Pathology Structures for Automated Differentiation of Breast Cancer and High-Risk Proliferative Lesions.
Mercan E; Mehta S; Bartlett J; Shapiro LG; Weaver DL; Elmore JG
JAMA Netw Open; 2019 Aug; 2(8):e198777. PubMed ID: 31397859
[TBL] [Abstract][Full Text] [Related]
15. Immunocytochemical identification of cell types in benign and malignant breast diseases: variations in cell markers accompany the malignant state.
Rudland PS; Leinster SJ; Winstanley J; Green B; Atkinson M; Zakhour HD
J Histochem Cytochem; 1993 Apr; 41(4):543-53. PubMed ID: 8450194
[TBL] [Abstract][Full Text] [Related]
16. Spindle Cell Lesions of the Breast: A Diagnostic Algorithm.
Ni Y; Tse GM
Arch Pathol Lab Med; 2023 Jan; 147(1):30-37. PubMed ID: 35976671
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemistry in Dermatopathology and its Relevance in Clinical Practice.
Chatterjee D; Bhattacharjee R
Indian Dermatol Online J; 2018; 9(4):234-244. PubMed ID: 30050812
[TBL] [Abstract][Full Text] [Related]
18. Spindle cell lesions of the breast: a diagnostic approach.
Rakha EA; Brogi E; Castellano I; Quinn C
Virchows Arch; 2022 Jan; 480(1):127-145. PubMed ID: 34322734
[TBL] [Abstract][Full Text] [Related]
19. Results of a worldwide survey on the currently used histopathological diagnostic criteria for invasive lobular breast cancer.
De Schepper M; Vincent-Salomon A; Christgen M; Van Baelen K; Richard F; Tsuda H; Kurozumi S; Brito MJ; Cserni G; Schnitt S; Larsimont D; Kulka J; Fernandez PL; Rodríguez-Martínez P; Olivar AA; Melendez C; Van Bockstal M; Kovacs A; Varga Z; Wesseling J; Bhargava R; Boström P; Franchet C; Zambuko B; Matute G; Mueller S; Berghian A; Rakha E; van Diest PJ; Oesterreich S; Derksen PWB; Floris G; Desmedt C
Mod Pathol; 2022 Dec; 35(12):1812-1820. PubMed ID: 35922548
[TBL] [Abstract][Full Text] [Related]
20. The Role of Immunohistochemistry for Primary Oral Diagnosis in a Brazilian Oral Pathology Service.
Araújo ALD; Fonsêca JM; do Amaral-Silva GK; de Lima Morais TM; Mariz BALA; Fonseca FP; Lopes MA; Vargas PA; Santos-Silva AR; de Almeida OP
Appl Immunohistochem Mol Morphol; 2021 Nov-Dec 01; 29(10):781-790. PubMed ID: 34320560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
